Angiogenic potential of mesenchymal stem cells derived from patients with diabetes seeded on decellularized micro fragments

J Diabetes Complications. 2021 Oct;35(10):108001. doi: 10.1016/j.jdiacomp.2021.108001. Epub 2021 Aug 3.

Abstract

Mesenchymal stem cells (MSCs) are a potential source of angiogenic factors which may promote wound healing in poorly vascularized diabetic foot ulcers. We demonstrate that MSCs of patients with diabetic foot ulcers seeded on decellularized micro-fragments transcribe and secrete angiogenic factors in amounts comparable to MSCs derived from healthy individuals.

Keywords: Angiogenesis; Angiogenic factors; Diabetes; Mesenchymal stem cells; Tissue engineering.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inducing Agents / metabolism*
  • Diabetes Mellitus*
  • Diabetic Foot* / therapy
  • Humans
  • Mesenchymal Stem Cell Transplantation*
  • Mesenchymal Stem Cells* / cytology
  • Wound Healing

Substances

  • Angiogenesis Inducing Agents